NLC Health Ventures

Driving real impact in healthcare. Meet these incredible group of experts. 🚀 We are dedicated to making a meaningful difference, but we know true impact isn’t created alone. That’s why, in 2024, we launched the #Impact Council! This is a group of experts from across our stakeholder network who have worked directly with patients, offering us valuable insights into the healthcare landscape and the impact of emerging innovations. By providing strategic guidance and hands-on support, they help our ventures scale and drive lasting change in the industry. A huge thank you to our Impact Council, Fenna Heyning MD PhD, Rhea Sims, MSc, BSN, RN and Katell Maguet for their invaluable input on the 2024 Impact Report, ensuring we measure our success accurately and identify ways to improve. Check out the 2024 Impact Report: https://lnkd.in/ea_yhayW Together, we’re shaping the future of healthcare! 💙 #HealthcareInnovation #HealthTech #NLCImpactCouncil

NLC takes on #LSIUSA25 for an exciting week of discussions with ventures investors and strategics! 🚀 Last week, Kim High, Jaap Haemers, Henk Westendorp and Pieter Wijffels visited #LSI25USA at Dana Point, LA, alongside 6 of NLC's portfolio companies. The event was impeccably organized and the southern California weather certainly did help to foster warm conversations. ☀️ Some key insights we learned: * 𝗢𝗽𝘁𝗶𝗺𝗶𝘀𝘁𝗶𝗰 𝗮𝗯𝗼𝘂𝘁 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: Despite the recent turmoil in the global ecosystem, there is a continued optimism about the future of healthtech and the need for innovation * 𝗛𝗲𝗮𝗹𝘁𝗵𝘁𝗲𝗰𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗴𝗹𝗼𝗯𝗮𝗹: Cross-border collaboration is essential, and a strong innovation ecosystem is critical worldwide * 𝗘𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲: Angel investment remains strong, while healthcare systems and government agencies are playing a growing role A huge thank you to Scott Pantel and the #LSIUSA25 team for another outstanding conference! Looking forward to reconnecting at LSI London and Singapore! #Innovation #VentureBuilding #USA #NLC

🚀 How AI is transforming healthcare. Featuring Alessandro Radaelli on navigating abroad by Launch Consulting Group! AI is revolutionizing #healthcare by enhancing diagnostics, streamlining workflows, and supporting physicians. But what does real-world adoption look like? In an episode of Navigating Abroad, hosted by Launch Consulting Group, our Venture Partner Alessandro Radaelli explores how AI and data-driven innovation are shaping the future of medtech, digital health, and biotech Key takeaways from the episode: 🔹AI-powered diagnostics: From early lung cancer detection to predicting strokes 🔹AI & robotics in surgery:  The use of AI in surgery and the improving precision, automating workflows, and redefining procedures 🔹Overcoming AI adoption challenges: How hospitals can integrate AI and how startups can break through barriers 🔹The role of data – Why accessibility, privacy, and validation are critical for AI-driven healthcare innovation 🔹AI as a support tool – optimizing, not replacing, the expertise of doctors and radiologists Share your thoughts in the comments below on what it takes to bring AI solutions from concept to real-world impact. 🎧 Watch full episode now : https://lnkd.in/ezHiVKRi #AIinHealthcare #NLC #HealthcareInnovation

🔬 Advancing rare disease research! Last week, Ankita Das attended the #XXII Scientific Convention organized by Fondazione Telethon in Rimini, Italy! 🇮🇹 Highlights of the event: • The event showcased groundbreaking #RareDiseaseResearch, all funded by Telethon, ensuring a strong focus on patient impact. • We explored early-stage innovations emerging from top universities and research institutes across Italy • A fantastic opportunity to connect directly with researchers, introducing them to venture building and how we help translate their research into #clinical impact! A huge thank you to Fondazione Telethon for an inspiring event!   #BiotechInnovation #VentureBuilding #HealthTech #FutureOfMedicine #LifeSciences

Impact in Life Sciences: Insights from the 3rd VC Impact Day 🚀 On Wednesday, we co-hosted a transformative event alongside Dr. Stephanie Mooij from Gilde Healthcare and Silva Deželan, PhD from Forbion.   Together, with 25 impact investor representatives, we explored how impact-driven approaches are reshaping life sciences investment. What made this gathering special? The genuine contribution and conversation between investors committed to measuring  #impact in the life sciences.  Our discussions centered on: 🔹 Patient engagement – Exploring how to involve patients from the earliest stages of development and the value this creates for both #investors and #ventures, ultimately supporting companies that develop products that truly benefit patients. Thank you to Patients Focused Medicine Development (PFMD) for leading this session and Gilde Healthcare for their insights and white paper. 🔹 Open dialogue on impact in life sciences – Covering topics from meaningful impact data, aggregation to impact carry, and what we would like to further develop as a network of like minded investors. 🔹 Introducing the LiFE Framework, an impact measurement framework developed by  Invest-NL, Coöperatie VGZ and others Dutch impact investors, and perspectives on its application by Ansana, featuring Leoni Delsink (VGZ) and Stanleyson Hato (Invest-NL). Looking to connect with other investors passionate about impact in life sciences? Comment below and let's expand this community together. Thank you for contributing to valuable discussions: Gilde Healthcare Trill Impact Forbion Thuja Capital Hadean Ventures NLC Health Ventures Ship2B Ventures, Novo Holdings EQT Life Sciences, Andera Partners, AXA Investment Managers, Invest-NL, Sofinnova Partners, Aliath Bioventures, SV Health Investors, Sound Bioventures, @AMRactionfund #LifeSciences #ImpactInvesting #NLCHealth #PatientEngagement

Innovation that empowers healthcare professionals ✨ "Imagine a world where healthcare workers can focus entirely on what matters most: their patients." - Bert-Arjan Millenaar, CEO & Founder NLC Health Ventures Healthcare faces challenges, from staff shortages to demanding workloads.  But innovation is making a real difference to improve and support the healthcare industry. We believe in challenging the status quo, not just accepting it. 💙 A breakthrough gel that makes severe burn treatment simpler, less painful, and more effective. 🤖 AI-powered diagnostics that help doctors detect cancer faster and more accurately, giving them more time for patients. 🔬 Smart technologies that ease workloads, boost efficiency, and enhance care quality. These innovations aren’t just ideas, they’re real ventures creating a healthier future.  Discover the impact in our 2024 report and join us in shaping the future of healthcare! 🔗 https://lnkd.in/eD6fsf4V #HealthcareInnovation #Impact #NLCVentures #NLC #HappyWorkforce

We are proud of Marta Scali, who secured 2nd place in the inaugural edition of Protagonisti dell’Innovazione - Categoria Investitori by INNLIFES!  🚀 Marta shared the podium with two remarkable women driving life sciences investment in Italy: Claudia Pingue (CDP) and Federica Draghi (XGEN Venture). A fantastic recognition of their impact in shaping the future of healthcare innovation! The event highlighted key insights into Italy’s evolving life sciences ecosystem: • VC Growth: Italy’s venture capital market is expanding but still catching up with the rest of the EU. • Bridging the Gap: Italy excels in Intellectual Property (IP) but faces challenges in commercializing innovations. • The Role of NLC: With VCs focusing on later-stage technologies, early-stage innovations need support—this is where NLC Health Ventures steps in! Congratulations Marta! #HealthcareInnovation #Innovation #WomenInvestors #ImpactInvesting

Reflecting on a successful event on #impact investing! Last Thursday we hosted, in collaboration with FIN - Branchevereniging van fondsen en foundations (the Dutch Association of Foundations), an event on impact investing. It was great to welcome different foundation members to discuss the opportunities and challenges of impact investing. With insightful talks from industry experts, we explored: ✅ The latest legal and regulatory developments for ANBIs ✅ What impact investing truly means and its associated risks ✅ The differences between investing in funds vs. direct investments ✅ A real-life case study from Stichting mr. Roelsefonds on transitioning to impact investing ✅ How to measure impact effectively in investment funds A big thank you to our speakers Siep Wijsenbeek,Laure Wessemius-Chibrac, Matthijs Blokhuis, Marc J.M. Petit, Johanneke Maenhout, and Hidde ten Brink for sharing their expertise. And of course, thanks to everyone who attended the event! Looking forward to continuing the conversation and driving positive change together! Noaber, FIN - Branchevereniging van fondsen en foundations,Netherlands Advisory Board on Impact Investing, Stichting mr. Roelsefonds #ImpactInvesting  #Foundations #NLCHealthVentures #FIN

𝗕𝘂𝗶𝗹𝗱 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁! 𝗛𝗲𝗮𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗥𝗲𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝘁 𝗡𝗟𝗖 𝗛𝗲𝗮𝗹𝘁𝗵 𝗩𝗲𝗻𝘁𝘂𝗿𝗲𝘀! 🚀 Imagine being the architect of our investor network, connecting groundbreaking healthtech innovations with the capital they need to thrive. At NLC Health Ventures, we’re seeking a visionary Head of Investor Relations to further develop and lead our IR function. Why this role matters: • Shape the future of healthcare by driving investment into cutting-edge ventures. • Build and manage relationships with top-tier institutional investors and family offices. • Lead fundraising efforts and be a key player in our growth story. • Work in a dynamic, impactful environment where your contributions make a real difference. This is an opportunity to be a catalyst for change and leave a lasting mark on the healthtech landscape. Interested? Apply here: https://lnkd.in/eNGDsxC7 #Healthtech #VentureCapital #InvestorRelations #Fundraising #Leadership #Innovation #NLC #CareerOpportunity #Investment

US-EU Collaboration: From Governor Walz's visit to #LSIUSA25 🚀 Three weeks ago, we welcomed Minnesota Governor Tim Walz to our offices in Amsterdam for a breakfast with senior stakeholders. The big question on the table: “Is the US open for business?” The answer was clear: Yes With shared values, common goals, and a joint commitment to progress, collaboration between European and US organizations is not just possible, it’s essential. Now, we’re taking the next step. Kim High, Henk Westendorp, Jaap Haemers, and Pieter Wijffels will be at the LSI USA, March 17-21 in Dana Point, USA. Let’s connect! #Healthtech #Innovation #USBusiness #Collaboration #LSIUSA25